Skip to main content
PMC home page
eLife logoLink to eLife
. 2015 Aug 4;4:e07335. doi: 10.7554/eLife.07335

Species-wide whole genome sequencing reveals historical global spread and recent local persistence in Shigella flexneri

Thomas R Connor 1,2,*,†, Clare R Barker 1,†, Kate S Baker 2,†, François-Xavier Weill 3, Kaisar Ali Talukder 4, Anthony M Smith 5, Stephen Baker 6,7,8, Malika Gouali 3, Duy Pham Thanh 6,7,8, Ishrat Jahan Azmi 4, Wanderley Dias da Silveira 9, Torsten Semmler 10,11, Lothar H Wieler 10,11, Claire Jenkins 12, Alejandro Cravioto 13, Shah M Faruque 4, Julian Parkhill 2, Dong Wook Kim 14, Karen H Keddy 5, Nicholas R Thomson 2,8
Editor: Diethard Tautz15
PMCID: PMC4522646  PMID: 26238191

Abstract

Shigella flexneri is the most common cause of bacterial dysentery in low-income countries. Despite this, S. flexneri remains largely unexplored from a genomic standpoint and is still described using a vocabulary based on serotyping reactions developed over half-a-century ago. Here we combine whole genome sequencing with geographical and temporal data to examine the natural history of the species. Our analysis subdivides S. flexneri into seven phylogenetic groups (PGs); each containing two-or-more serotypes and characterised by distinct virulence gene complement and geographic range. Within the S. flexneri PGs we identify geographically restricted sub-lineages that appear to have persistently colonised regions for many decades to over 100 years. Although we found abundant evidence of antimicrobial resistance (AMR) determinant acquisition, our dataset shows no evidence of subsequent intercontinental spread of antimicrobial resistant strains. The pattern of colonisation and AMR gene acquisition suggest that S. flexneri has a distinct life-cycle involving local persistence.

DOI: http://dx.doi.org/10.7554/eLife.07335.001

Research organism: E. coli, other

eLife digest

Dysentery is a disease in which the intestine becomes inflamed due to infection by bacteria, viruses or other microbes. Of the bacteria that can cause dysentery, bacteria called Shigella are most often responsible. Humans can acquire Shigella through contaminated food or water. Over the last century, improvements to sanitation combined with access to clean drinking water and better food hygiene have decreased the number of cases of dysentery in many countries. However, the disease continues to be common in low-income countries, especially in young children.

One species of Shigella bacteria, called S. flexneri, causes far more cases of dysentry than other species of Shigella. Across the world, there are many different strains of S. flexneri, but it is not clear how these strains are related to each other, or how variable the genes that they carry are—known as genetic diversity.

Here, Connor, Barker, Baker et al. used a technique called whole genome sequencing to map the evolutionary relationships of over 300 S. flexneri samples collected from around the globe over the past 100 years. This revealed that the bacterial strains can be split into seven groups that each have distinct geographic ranges and combinations of genes that enable the bacteria to infect humans. Many of the strains of bacteria within these groups seem to have colonized, and remained in, quite small geographic areas over long periods of time. This is different to other Shigella species, which appear to have spread between continents far more frequently over much shorter timescales.

Connor, Barker, Baker et al.'s findings reveal that S. flexneri is more diverse than other Shigella bacteria, and suggest that the ability of strains to persist in local areas may have contributed to the species' long-term success. These results point towards the importance of the provision of clean water in the fight against S. flexneri, and underline the need for a greater understanding of how disease-causing bacteria colonize and interact with the local environment.

DOI: http://dx.doi.org/10.7554/eLife.07335.002

Introduction

Once a major cause of mortality and morbidity in Europe and the US prior to the widespread provision of reliable sanitation systems and clean drinking water, bacterial dysentery caused by Shigella spp., remains a significant infection in low-income countries (Kotloff et al., 2013). While the Shigellae are, phylogenetically, Escherichia coli, they were originally classified as separate species based upon shared disease and biochemical phenotypes that marked them out as distinct from other E. coli strains—a distinction that is still reflected in their species nomenclature because of continued global medical importance. The ‘genus’ Shigella consists of four species (Shigella flexneri, Shigella sonnei, Shigella boydii and Shigella dysenteriae) causes approximately 165 million new infections globally per year (Kotloff et al., 1999; Ram et al., 2008), which have previously been estimated to result in up to 1 million deaths annually (Kotloff et al., 1999, 2013). The vast majority of cases and fatalities occur in low to middle-income countries in children under the age of 5 years (Kotloff et al., 1999; von Seidlein et al., 2006). The preponderance of these cases are attributable to endemic disease caused by the species S. flexneri (Vinh et al., 2009; Ud-Din et al., 2013; Livio et al., 2014). Despite the importance of S. flexneri as an etiological agent of diarrheal disease globally, little is known about its detailed population structure. This knowledge gap is a substantial limitation as the ability to accurately track bacterial pathogens is a cornerstone of effective surveillance and downstream public health interventions.

This poor understanding of S. flexneri is partly a result of a lack of high-resolution tools for subtyping this species. Traditionally S. flexneri strains are subdivided based on the antigenic variation of the O-antigen component of the bacterial lipopolysaccharide (LPS) using typing antisera and the slide agglutination method (serotyping). Serotyping currently subdivides isolates into serotypes or subserotypes by the use of type-specific and group factors antisera (Edwards and Ewing, 1986; Sun et al., 2011). Although serotyping still forms the central vocabulary for describing this species it is now widely agreed that many genes that determine serotype are encoded on horizontally transmissible genetic elements (Allison and Verma, 2000), thus facilitating serotype switching. Therefore the extent to which core characteristics of the species that are currently inferred based on serotype relate to the phylogenetic relationships of strains remains open to question.

Through limited genetic and genomic studies we know that Shigella spp. represent distinct clades that fall within the E. coli species complex (Pupo et al., 2000; Yang et al., 2005, 2007; Ashton et al., 2014; Sahl et al., 2015). These studies show the existence of two distinct S. flexneri lineages, with one lineage including only a single serotype (S. flexneri 6) (Choi et al., 2007) that clusters within species S. boydii (Yang et al., 2007) and possesses a different LPS O-antigen. The second monophyletic S. flexneri group contains representatives of all other S. flexneri serotypes (1–5, X, Y) and is responsible for the majority of S. flexneri disease; it is this main lineage that is examined here.

Whole genome sequencing has been used successfully to uncover key aspects of the provenance as well as global and regional epidemiology of other Shigella species. Work on the now rarely isolated (von Seidlein et al., 2006), S. dysenteriae type 1 has shown it to be an epidemic pathogen characterised by sporadic, large scale outbreaks that spread rapidly and widely via a series of intercontinental transmissions, often associated with war or famine (Rohmer et al., 2014). Studies examining the dominant endemic Shigella species of industrialised and newly industrialised countries, S. sonnei, have also revealed a species that is highly clonal (Karaolis et al., 1994; Holt et al., 2012). S. sonnei evolved in Europe ∼300 years ago and has recently moved out of this region via intercontinental spread as a single, rapidly evolving lineage, establishing new, local, populations in countries as they industrialise (Holt et al., 2012, 2013). The contrast between the distribution of the two endemic Shigella species, S. sonnei and S. flexneri, has posed the question why is it that two different species predominate under very different socio-economic conditions (Kotloff et al., 1999)? S. flexneri remains the dominant species in low-income countries (multiple studies report over 50% of all cases of shigellosis [Kotloff et al., 1999, 2013; Livio et al., 2014]), whereas S. sonnei is the most commonly isolated Shigella species in industrialised countries (77% of cases as reported by Kotloff et al., 1999) where there is better sanitation and access to clean food and drinking water. The reasons for these differences are poorly understood, as are specific transmission patterns that may account for the variation in the dominant Shigella species in these differing settings.

To further our understanding of the evolution, population structure and phylogeography of S. flexneri we gathered a representative global collection of 351 isolates of S. flexneri, spanning serotypes 1–5, X, Xv and Y, collected from the contemporary principal foci of endemic disease; Africa, Asia and South and Central America as well as historical isolates from reference collections dating back to 1914 (Supplementary file 1). We performed whole genome sequencing on the sample set to provide a basis for exploring the relationship of strain, serotype and geography. Our analysis reveals that S. flexneri is composed of phylogenetically distinct lineages, with each lineage holding similar levels of diversity to the entire S. sonnei species. We observe that the natural history of S. flexneri is characterised by long term (in some cases over 100 years) colonisation of individual countries demonstrating that it is far older, and far more diverse than S. sonnei. From this, our analysis uncovers further key differences between the population structure of these two species; providing new clues as to the reasons for the persistence, and most recently decline of S. flexneri.

Results

The genomic population structure of S. flexneri

To determine a detailed phylogeny of this species we mapped the sequence reads from the 351 S. flexneri strains to the concatenated reference genome of S. flexneri strain 301, including its virulence plasmid (VP), to detect single nucleotide polymorphisms (SNPs). SNPs falling in transposases, IS elements, repeats or regions identified as being recombinant (Figure 1—figure supplement 1) and unlikely to reflect the underlying phylogeny of the bacterium, were excluded from this analysis. We identified 67,981 SNPs among the 352 genomes (including reference genome), with 63,186 of these on the chromosome and 4795 on the VP. Following the removal of recombinant regions (almost entirely concentrated in phage, IS elements and S. flexneri Pathogenic Islands, Figure 1—figure supplement 1), 55,662 SNPs remained in total, with 53,078 on the chromosome and 2584 on the VP. From these SNPs we inferred a maximum likelihood phylogeny showing that the population of S. flexneri is composed of several pylogenetically distinct lineages (Figure 1, Figure 1—figure supplement 2). To unambiguously subdivide the species based on shared patterns of sequence variation, we used the software package Bayesian analysis of population structure (BAPS) (Cheng et al., 2011, 2013) to identify robust phylogenetic groups (PGs) within S. flexneri. This subdivided the population into seven PGs, concordant with the phylogeny (Figure 1). Performing the BAPS analysis on alignments of the chromosome and VP collectively or individually resulted in the same pattern of clustering, reflecting that the VP phylogeny precisely mirrors that of the chromosome, indicating co-evolution (Figure 1—figure supplement 3).

Figure 1. Maximum likelihood phylogeny for Shigella flexneri isolates including serotypes 1–5, X and Y produced from the results of mapping sequence reads against the genome of S. flexneri 2a strain 301, with recombination removed.

Phylogenetic groups (PGs) determined by Bayesian analysis of population structure clustering are boxed within dotted lines, with the geographic and serotype composition of isolates in each PG being inlaid as pie charts.

DOI: http://dx.doi.org/10.7554/eLife.07335.003

Figure 1.

Figure 1—figure supplement 1. Location of segments detected as recombinant.

Figure 1—figure supplement 1.

Blue indicates a likely recombination within an individual isolate while red indicated recombination common to multiple isolates. Green text at the top indicates mobile elements determined by a manual examination of the reference S. flexneri strain 301 genome.
DOI: http://dx.doi.org/10.7554/eLife.07335.004
Figure 1—figure supplement 2. S. flexneri species tree, with the number of single nucleotide polymorphisms (SNPs) per branch.

Figure 1—figure supplement 2.

The SNP tree uses the same alignment as in Figure 1, but is constructed from the SNPs that can be assigned to each branch. The ancestral states were reconstructed using ACTRAN. Insert—a table showing the number of SNPs between the most recent common ancestor (MRCA) of each of the PGs identified.
DOI: http://dx.doi.org/10.7554/eLife.07335.005
Figure 1—figure supplement 3. Co-evolutionary relationships of the S. flexneri genome and virulence plasmid (VP).

Figure 1—figure supplement 3.

A maximum likelihood phylogeny of the S. flexneri chromosome (left) is shown adjacent to one of the VP (right). Collared blocks and labels enclose independently identified BAPs clusters for sequence alignments of the chromosome and VP. Dotted lines indicate groups of isolates shared between clusters in phylogeny.
DOI: http://dx.doi.org/10.7554/eLife.07335.006
Figure 1—figure supplement 4. Maximum Clade Credibility trees generated using Bayesian evolutionary analysis by sampling trees (BEAST) for PG 1.

Figure 1—figure supplement 4.

Dates of MRCA are shown overlying internal nodes followed by 95% HPD in parentheses. Tips display the country of origin for each isolate (where available), coloured by region while the date given in red at the base of each group is the MRCA date obtained from the software Path-O-Gen, calculated based on the root-to-tip distance. The horizontal scale is in the unit of years in the past.
DOI: http://dx.doi.org/10.7554/eLife.07335.007
Figure 1—figure supplement 5. Maximum Clade Credibility trees generated using BEAST for PG 2.

Figure 1—figure supplement 5.

Dates of MRCA are shown overlying internal nodes followed by 95% HPD in parentheses. Tips display the country of origin for each isolate (where available), coloured by region while the date given in red at the base of each group is the MRCA date obtained from the software Path-O-Gen, calculated based on the root-to-tip distance. The horizontal scale is in the unit of years in the past.
DOI: http://dx.doi.org/10.7554/eLife.07335.008
Figure 1—figure supplement 6. Maximum Clade Credibility trees generated using BEAST for PG 3.

Figure 1—figure supplement 6.

Dates of MRCA are shown overlying internal nodes followed by 95% HPD in parentheses. Tips display the country of origin for each isolate (where available), coloured by region while the date given in red at the base of each group is the MRCA date obtained from the software Path-O-Gen, calculated based on the root-to-tip distance. The horizontal scale is in the unit of years in the past.
DOI: http://dx.doi.org/10.7554/eLife.07335.009
Figure 1—figure supplement 7. Maximum Clade Credibility trees generated using BEAST for PG 5.

Figure 1—figure supplement 7.

Dates of MRCA are shown overlying internal nodes followed by 95% HPD in parentheses. Tips display the country of origin for each isolate (where available), coloured by region while the date given in red at the base of each group is the MRCA date obtained from the software Path-O-Gen, calculated based on the root-to-tip distance. The horizontal scale is in the unit of years in the past.
DOI: http://dx.doi.org/10.7554/eLife.07335.010
Open in a new tab

The natural history of S. flexneri

Genetic clustering of the population and the phylogenetic tree revealed a species that is composed of seven discrete PGs, separated by considerable evolutionary distance (ranging from 1138 to 8430 SNPs between PGs—Figure 1—figure supplement 2), this analysis provided only limited information regarding the natural history of the organism. Most of the PGs contained organisms from several geographic regions, and significantly all PGs contained samples collected over a period of at least 60 years. To combine the geographic and temporal metadata with the genomic information, we used Bayesian evolutionary analysis by sampling trees (BEAST) (Drummond and Rambaut, 2007) to reconstruct the temporal and geographical history of the major PGs. Inferring evolutionary rates and estimating the dates of the most recent common ancestor (MRCA) of individual PGs, we found that rates of mutation were similar among PGs (between 6.46 × 10−7 substitutions per site per year [PG1] to 9.54 × 10−7 substitutions per site per year [PG2]). These mutation rates are consistent with previous estimates for S. flexneri (3.2 × 10−7 substitutions per site per year [Zhang et al., 2014]), S. sonnei (6.0 × 10−7 substitutions per site per year [Holt et al., 2012]) and S. dysenteriae (6.52 × 10−7 substitutions per site per year [Rohmer et al., 2014]). Using these data we predicted the MRCA of each PG, finding that the median age of the MRCA for all PGs was between 150 and 900 years ago (Figure 1, Figure 1—figure supplements 4–7). Of the PGs, PG1, 2, 4 and 6 are the oldest lineages with median BEAST estimate of MRCAs of these groups dating to between 1341 and 1659. Contrastingly, PG5 and PG3, the latter containing the majority of serotype 2a isolates—one of the key suggested S. flexneri vaccine targets—are much younger, and these PGs have median estimated MRCAs dating to 1822 (PG5) and 1848 (PG3); contemporaneous with the MRCA of the emergence of S. sonnei from Europe. However, unlike S. sonnei, the emergence of new S. flexneri PGs did not appear to result in displacement or replacement of isolates from other PGs; rather the older PGs have persisted and continue to cause disease alongside the newer PGs, as evidenced by the fact that every PG contains at least one strain collected since 2008 (Supplementary file 1).

The intercontinental spread of S. flexneri

One of the most striking features of the S. sonnei population was the recent intercontinental spread of the organism. Analysing our dataset using the discrete states phylogeographic analysis implemented in BEAST we observed a contrasting natural history of S. flexneri PGs 1–7 with respect to S. sonnei (Holt et al., 2012). We observed considerable genomic diversity in S. flexneri isolates collected from the same region. Regions where S. flexneri is endemic simultaneously supported at least two populations of S. flexneri originating from distinct PGs; with the Indian subcontinent having geographically-monophyletic sublineages from four different PGs (Figure 1, Figure 1—figure supplements 4–6, Figure 2). None of these sublineages are recently introduced into these regions; most geographically monophyletic sublineages within the PGs had MRCAs in the range of 25–150 years. As well as observing isolates from different genomic backgrounds coexisting in the same geographic area, our data also show that sublineages from the same PG can also persist contemporaneously in the same geographical region, over an extended period of time (Figure 1—figure supplements 4, 6).

Figure 2. Correlation of isolate phylogeny with pathogenicity and antimicrobial resistance (AMR) determinants.

The midpoint-rooted maximum likelihood phylogenetic tree shows PGs, with tips and terminal branches collared by continent of origin. Tracks adjacent to each isolate show the percentage BLAST identity of the best hit in the sample assembly against key virulence and AMR determinants. Isolates with mutations in the gyr/par genes have black bars in the relevant tracks. The virulence determinants shown are SHI-1 (pic, sigA, set1AB), SHI-2 (shiABCDE, iucABCD, iutA), sat, enterobactin (entABECFD, fepABCDG), sitABCD, fecEDCBAR, stx1ab, fimZBCHGFDEAY, and the AMR genes are aac(3)-II, aadA1, aadA2, aadA5, strA, strB, sat1 (aminioglycosides), blaCTX-M-24, blaOXA-1, blaTEM-1, (β-lactams) ermB, msrE, mphA, mphE, (macrolides) catA1, catB1, (phenicols) qacEΔ1, qnrS1, (quinolones) qepA, sul1, sul2 (sulphonamides) tetA(A), tetA(D), tetA(B) (tetracyclin), dfrA17, dfrA3b, dfrA1, dfrA5, dfrA14 and dfrA8 (trimethoprim).

DOI: http://dx.doi.org/10.7554/eLife.07335.011

Figure 2.

Figure 2—figure supplement 1. Results of molecular serotyping, displaying the distribution of MLST, molecular serotype, and the distribution of defining genes (according to key, top left) among isolates.

Figure 2—figure supplement 1.

DOI: http://dx.doi.org/10.7554/eLife.07335.012
Figure 2—figure supplement 2. Maximum likelihood phylogeny of an alignment of the concatenated nucleotide sequences the enterobactin locus of 13 genes (34,732 NT; containing entABCDEFS, fepABCDG and fes).

Figure 2—figure supplement 2.

The tree is drawn using PhyML, with a GTR model and contains 191 strains. Isolate labels are collared according to whole-genome based PG definition.
DOI: http://dx.doi.org/10.7554/eLife.07335.013
Figure 2—figure supplement 3. Correlation of isolate phylogeny with AMR determinants, showing only the SRL-MDRE-associated loci aadA1, blaOXA-1, cat and tetA(B).

Figure 2—figure supplement 3.

Grey circles indicate branches where acquisition events are predicted to have taken place.
DOI: http://dx.doi.org/10.7554/eLife.07335.014
Open in a new tab

Despite this structure of long-term phylogeographic association on a population wide level, we also observe that some PGs were highly geographically restricted and appear to have spread to only a limited number of regions. For example, PG2 has a MRCA dated to 1550 (95% CI: 1340–1725), with Asian isolates appearing in both sublineages of this cluster (Figure 1—figure supplement 5). The MRCA for the Asian isolates was estimated to be 1544; however the African isolates form a single cluster that has a more recent MRCA—dated to 1885 (95% CI: 1833–1923); a result that implies that PG2 S. flexneri was likely introduced into Africa from Asia at least 130 years ago. However, it is also important to note that while there is always a possibility of sample bias; within our dataset there is a clear signal that the African and Asian lineages are distinct, and have been for some time. Other samples may change this view, however, the sampling strategy we used was to collect samples globally—capturing a cross section of current disease with a historical view of the population of S. flexneri—without a specific focus on a single serotype grouping or geographic region. The fact that clear clusters within the population associated with geographic origin do appear would not be expected by chance.

The genome of S. flexneri is stable, with recombination mostly limited to mobile elements

Perhaps surprisingly for a gastrointestinal pathogen of the E. coli complex, at least on a population level, we found very limited evidence of large-scale species-wide recombination within the genome (Figure 1—figure supplement 1), with S. flexneri displaying a recombination profile more in line with the lifestyle-restricted ST131 than with members of other gastrointestinal pathovars such as ETEC (McNally et al., 2013). Within the virulence repertoire, where recombination could be identified, it was generally present among all isolates within a single PG(s), indicating that the recombination was likely to be ancestral occurring prior to PG divergence. Furthermore, most evident recombination is restricted to previously identified mobile genetic elements (Figure 1—figure supplement 1).

By examining known chromosomally encoded virulence determinants, it is clear that many known virulence functions are ubiquitous to all PGs (Figure 2). The distribution of virulence determinants indicated that many of the genes/islands whose loss is known to attenuate S. flexneri virulence (such as the VP [Sansonetti et al., 1982] and aerobactin [Lawlor et al., 1987; Wyckoff et al., 2009]) were acquired early in its evolutionary history and have been subsequently retained. However, some variation in the composition of virulence determinants is also evident. For example, Sat, a Serine Protease Autotransporter, is found in PGs 2, 4, and 7, but absent from PGs 1, 3, 5 or 6 (Figure 2). Although the latter PGs possess a genetic scar suggesting that Sat was present ancestrally and has been subsequently lost.

We also find that the SHI-1 pathogenicity island—a distinguishing feature of serotype 2a (the dominant serotype causing disease world-wide [Kotloff et al., 1999])—was acquired once (between 1848 and 1882) near to the root of PG3. SHI-1 carries genes encoding three key virulence associated proteins—Pic, (Henderson et al., 1999) SigA (Al-Hasani et al., 2000), and the S. flexneri enterotoxin ShET1 (Fasano et al., 1997). Pic, which is also found in Enteroaggregative E. coli, encodes a secreted protease that has been shown to have mucinase activity and has been suggested to be involved in haemagglutination and serum resistance (Henderson et al., 1999). SigA is thought to be involved in fluid accumulation (Al-Hasani et al., 2000), while the S. flexneri enterotoxin ShET1 has also been shown to be involved in fluid accumulation in rabbit ileal loop models (Fasano et al., 1997), and has been proposed as being the causative agent of the voluminous watery diarrhoea characteristic of a S. flexneri serotype 2a infection (Noriega et al., 1995; Fasano et al., 1997). Although SHI-1 is only present in PG3 (135 of 146 PG3 isolates included carried this island), it is present in the range of serotypes found within this phylogroup—including multiple isolates of serotypes 1a, 2a, 2b and 5a. This demonstrates that the toxin is not peculiar to strains carrying a particular serotype, but rather to strains within a PG that are predominantly serotype 2a; consistent with reports of a small number of non-2a serotypes reported to encode this toxin (Noriega et al., 1995). Our genomic data further confirm that these cases were not simply mis-serotyped, but likely represent cases of sporadic serotype switching amongst isolates within PG3.

More generally, we observe evidence for recombination amongst the genes responsible for serotype (see gtr Figure 1—figure supplement 1), which remains the de-facto method for describing strains of Shigella. When cross comparing the classical and in silico molecular serotyping schemes (Sun et al., 2011) we saw no significant difference in the serotypes predicted (assessed using a Kolmogorov–Smirnov test). However, our results do demonstrate that while certain serotypes make up the majority of certain clusters (Figure 1, Figure 2—figure supplement 1), all of the PGs contained multiple serotypes. This indicates that although the core genome is remarkably stable, serotype switching does occur undermining the principle that serotype can be used either as a basis for describing the properties of a lineage or for epidemiological surveillance and tracking. These results also imply that vaccines targeting a particular backbone using a serotype (such as a 2a vaccine to target SHI-1 encoding isolates from PG3) could be susceptible to the effects of serotype switching.

In addition to our observations around SHI-1 and the VP we also observed some variation in virulence factor complement within PGs principally for Iron uptake functions; the sit (Runyen-Janecky et al., 2003) and fec loci (Luck et al., 2001) and enterobactin biosynthesis operon. Across our S. flexneri tree it is apparent that these have contrasting patterns of gain and loss; sit is ancestral, but was sporadically lost (unexpectedly, as it has been reported to be in all clinical isolates previously [Runyen-Janecky et al., 2003]), while fec has been gained sporadically by isolates within PG3, as well as being gained (and retained) on separate occasions by isolates in PG1, 2 and 6. Of additional interest is the enterobactin operon; which encodes a high affinity iron siderophore (O'Brien and Gibson, 1970). It has previously been reported that in S. flexneri the enterobactin genes are ‘rarely utilized’ (Schmitt and Payne, 1988; Wyckoff et al., 2009; Reuter et al., 2014); however, our data show that the enterobactin genes are present across PGs 3, 5, 7 and 4, as well as a subset of related isolates within of PG1. Examining the enterobactin gene specifically, we observed the same phylogenetic topology as that observed for the whole genome tree (Figure 2, Figure 2—figure supplement 2); suggesting this element is ancestral, and has been lost by a subset of PGs. The ubiquitous nature of these enterobactin genes suggests that these genes are more significant than ‘rarely utilized’; as they have been retained by multiple PGs, over a long timescale.

In addition to these PG-wide patterns, within PG3 we observed six tightly clustered isolates that also carry a Shiga toxin 1a (Stx1a)-encoding phage (Figure 2) which is identical to the recently reported φPOC-J13 (accession number KJ603229) (Gray et al., 2014). These isolates were collected between 2003 and 2008 from Latin America (Haiti, French Guiana and the Dominican Republic). This is consistent with these findings charting the emergence of Stx1a-producing S. flexneri in the region (Gray et al., 2014). Given that the reference phage clusters phylogenetically within our sequenced isolates it is likely that the phage was acquired once in this sublineage of PG3. The dating analysis on the Stx-1-containing PG3 sublineage showed that the phage could have been acquired no later than 1998 (Figure 1—figure supplement 6) suggesting that strains carrying this phage may have been present but undetected in the population for 5–10 years before the earliest reported isolation of Stx1a-producing S. flexneri.

Antimicrobial resistance determinants have been gained and retained locally on multiple occasions independently by multiple lineages

Antimicrobial resistance (AMR) has been shown to be a strong influence on the recent evolutionary history of many bacterial pathogens (Mutreja et al., 2011; Holt et al., 2012; Okoro et al., 2012; He et al., 2013; Mather et al., 2013). Screening for the presence of known AMR genes (Figure 2) we found that AMR gene distribution was highly variable both within and across PGs (Figure 2). Unlike S. sonnei, we observe little evidence that the acquisition of AMR-related loci is linked to the establishment or replacement of dominant lineages in any geographic location. While published evidence does exist of one major, on-going, clonal outbreak of S. flexneri in high income countries that has been shown to be the result of a combination of specific epidemiological, AMR and behavioural factors within the MSM community (Baker et al., 2015), examining our dataset focused around historical isolates and those with an origin in low-income countries, we observe limited historical evidence of global expansion as a result of AMR. In contrast we observe the widespread acquisition of AMR determinants independently across the tree. The most widespread AMR loci are found on the multidrug resistance element (MDRE), part of the Shigella resistance locus-pathogenicity island (SRL-PAI) with variants found in representatives from all PGs. Our analysis suggests that the SRL-PAI has been introduced independently on at least nine occasions (Figure 2—figure supplement 3). In six of these it has been maintained in subsequent lineages for protracted periods of time. There is, however, no evidence of isolates carrying SRL-PAI spreading outside of their geographic region, and, once acquired, in a number of cases it appears that the SRL-MDRE may have been subsequently lost (Figure 2—figure supplement 3). Beyond the SRL-PAI we observe 23 internal branches where non SRL-PAI resistance determinants have been acquired (Figure 2), depicting a distinctive wave-like pattern of resistance determinant acquisition over time (Figure 3). The earliest resistance genes observed in the population code for sulphonamide resistance (1950s), followed by streptomycin and tetracycline (1960s) resistance, with β lactamases arising first in strains isolated in the 1970s (Figure 3A). Notably, we observe that in all cases within S. flexneri the strains acquiring AMR determinants remain geographically restricted, although on a population level we also observe an upward trend in AMR determinant possession over time, in all PGs (Figure 3B). We also observe that whilst AMR is widespread in the 21st century, we can isolate S. flexneri strains that do not harbour large numbers of AMR determinants; this is in marked contrast to observations within the S. sonnei population.

Figure 3. Graphs showing the pattern of AMR presence within our dataset.

Figure 3.

Open in a new tab

(A) Graph showing the proportion of isolates from each decade that contain the AMR genes. (B) Graph showing the average number of resistance genes found in each isolate collected, by year.

DOI: http://dx.doi.org/10.7554/eLife.07335.015

Discussion

Our results present the clearest and most complete overview of the temporal and geographic patterns that underpin the population structure of the species S. flexneri obtained to date. It provides a genetic framework and evolutionary context for studies looking within single countries or looking at individual outbreaks or lineages of interest. These data contrast with that of the other Shigella species for which we have global population data, S. sonnei and S. dysenteriae; with the pattern of long term colonisation, diversity and coexistence in S. flexneri lineages appearing to share more similarities with pathogenic E. coli variants such as ETEC (von Mentzer et al., 2014) than other Shigella species. It is evident from the presented data that, at a population level, S. flexneri is characterised by long-term colonisation of endemic regions, with limited evidence of intercontinental transmission within the last 30 years. Our data also suggest that endemic countries support a diverse population of S. flexneri, and have done for some time, implying long-term local-transmission/colonisation in those settings. This is in direct contrast to S. sonnei, where historically the population is characterised by recent colonisation of countries and dominant pandemic lineages, with frequent inter-country and inter-continental transmission and repeated strain replacement (Holt et al., 2012).

It is also evident that while AMR has had significant in the natural history of both species, the effects of AMR acquisition on the population are contrasting. For S. sonnei the acquisition of multiple AMR genes was strongly associated with lineage replacement by dominant resistant lineages, on a global scale. Whereas, for S. flexneri, we observe a population where there have been over 30 independent acquisitions of AMR determinants at a local level; but these acquisitions generally result in limited global spread (Figure 2). This implies that while AMR may be a significant factor in maintaining existing lineages within specific locales we do not see widespread evidence of AMR acquisition leading to the pandemic displacement of other pre-existing lineages. Moreover this observation also extends to the simultaneous acquisitions of multiple AMR genes en bloc, such as those associated with the SRL-PAI. The acquisition of this locus appeared to have occurred in lineages that, within this dataset, show no subsequent evidence of travel outside of their original geographic area. It may be that the transient nature of AMR gene carriage is the result of rapid gain and loss during periods of differential selection, consistent with S. flexneri persisting in the environment where it is conceivable that selection by AMR could be less significant. Despite this lack of evidence of rapid global spread of AMR, on a population level we did observe both an on-going trend of increasing resistance in S. flexneri, and evidence that this pathogen acquires resistance determinants rapidly, often keeping the AMR determinants for protracted periods. However, we also continue to observe recently collected strains with a low number of resistance determinants—suggesting that strains with a limited resistance repertoire are continuing to persist within the wider population. This observation suggests that although there is evidently some selective advantage to carrying AMR determinants, as evidenced by the increasing level of resistance across the pathogen population, it is not an absolute requirement for modern S. flexneri.

The contrast between the observed population structure, natural history and role of AMR in the narrative of S. flexneri and S. sonnei may be related to the lifecycle of these two organisms. It has previously been shown that S. flexneri strains can be recovered from the environment in endemic countries (Faruque et al., 2002) unlinked to any outbreak, and that under experimental conditions S. flexneri can survive for several months in water at room temperature (Uyanik et al., 2008), simulated environmental water (Hendricks and Morrison, 1967; Islam et al., 1996) and upon foodstuffs (Islam et al., 1993). Furthermore, there are multiple examples of S. flexneri outbreaks where the outbreak strain was traced back to, and isolated from local water sources (Swaddiwudhipong et al., 1995; He et al., 2009; Saha et al., 2009). In addition, at least one study has been undertaken that has demonstrated that within Bangladesh S. flexneri disease risk was persistent throughout the year and associated with environmental factors (geographic location/provision of flood defences) (Emch et al., 2008). When these studies are combined with both our results and additional observations that the provision of clean water and good sanitation correlates with a reduction in the rates of S. flexneri disease (Esrey et al., 1985), we believe that the implication is that in an environment where water is frequently persistently contaminated with faeces, S. flexneri, in effect, persists in the environment, and has been doing so over the long term, in countries around the world. A mechanism of environmental persistence would explain our observations around the longevity of lineages of S. flexneri in endemic countries and provide an obvious transmission mechanism. When considering the temporal and phylogeographic analyses presented here in this context, we think that the evidence supports the concept, suggested previously, that in endemic countries the lifecycle of S. flexneri disease is analogous to that of Vibrio cholerae (Faruque et al., 2002); with part of the pathogens infectious cycle being in contaminated water, from which it periodically emerges to cause disease. While our data suggests that an environmental stage may be important for S. flexneri—whose reduced incidence has previously been correlated with the provision of clean water and improved sanitation (Esrey et al., 1985), the inverse is true for S. sonnei. It has been suggested that the O-antigen carried by Plesiomonas shigelloides (another organism isolated from faecally contaminated water)—that is immunologically indistinguishable from the S. sonnei O-antigen may help to explain the contrasting global distribution of S. sonnei and S. flexneri infections (Sack et al., 1994). Exposure to P. shigelloides, through drinking contaminated ground water has been hypothesized to stimulate low level cross protective immunity against S. sonnei, explaining why it is rarely found in the resource poor settings but its incidence increases with water sanitation. If the P. shigelloides hypothesis is proved to be true, it may be that contaminated water holds the key to both the increase in S. sonnei and the decrease in S. flexneri observed as countries develop.

Collectively, our analyses outline a historic pathogen with a stable core genome that comes equipped with a repertoire of virulence determinants that have enabled it to colonise, and persist, in multiple locations for hundreds of years. However, this life-cycle is at odds with current patterns of human development; with temporal analysis revealing limited evidence of intercontinental transmission and local colonisation within the last 30 years. It may be that this change is reflective of the fact that over the course of the 20th Century, many countries have industrialised; with increasing provision of clean water and sanitation possibly disrupting the traditional transmission route of S. flexneri. However, despite its decline in industrialised countries, where transmission of this pathogen by faecally contaminated food and water is well controlled, S. flexneri continues, as it has done for hundreds of years, to be a source of disease infecting millions in the low-income nations of the world.

Materials and methods

Samples

Contemporaneous strains isolated from patients were collected from accredited diagnostic or Public Health laboratories located in Bangladesh (ICDDRB, n = 114), South Africa (National Institute for Communicable Diseases, Johannesburg, South Africa, n = 29), and, for Francophone Africa and Latin America, from the French National Reference Centre for E. coli, Shigella, and Salmonella (Institut Pasteur, n = 54) and the Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam (n = 34). A historical selection of isolates was obtained from the Institut Pasteur (n = 41) and The International Vaccine Institute and Hanyang University, Korea (n = 62), to provide a stronger temporal signal for the BEAST analysis. Additionally, we also included the HPA type strains (n = 16) (Ashton et al., 2014) and NCTC1 (Baker et al., 2014). Serotyping was performed on isolates using the standard tests used locally by the submitting lab (using either commercial or locally produced, polyclonal and monoclonal typing antisera), and the classical serotypes obtained were checked, and in most cases confirmed, using a molecular serotyping schema (Sun et al., 2011).

Sequencing

DNA was extracted by collecting laboratories and sequenced at the Wellcome Trust Sanger Institute to a minimum of 50-fold coverage using an Illumina HiSeq 2000 with multiplexing of 96 samples per flow cell using 100 bp paired end reads. Sequencing data was submitted to the ENA (Genome accession numbers provided in Supplementary file 1). To perform subsequent analyses around the AMR and virulence gene determinants, sequence data was assembled de novo using Velvet (Zerbino and Birney, 2008), with assemblies improved using iCORN (Otto et al., 2010) and the Velvet Columbus module.

Bioinformatics analysis

Phylogenetic and population genetic relationships were determined based on a similar approach to that employed by Holt et al. (2012) for S. sonnei. Sequence (FASTQ) files for each isolate in the study were mapped back against the reference S. flexneri serotype 2a strain 301 concatenated with its complete VP (Accession numbers: AE005674, AF386526). A whole genome alignment was produced by SNP-calling isolates, and regions that were recombinant were identified using the software package Gubbins (Croucher et al., 2014). The recombinant regions were subsequently manually checked and their content identified. Following removal of recombinant regions, mapping coverage was checked manually and variable sites were extracted. The resulting SNP alignment was used to infer a phylogeny using RAxML version 7.4 with a General Time Reversible model and gamma correction (n = 4) for among site rate variation (Stamatakis, 2006). The alignment produced prior to the removal of recombinant regions (66,524 bp in length) was passed to BAPS to identify phylogenetic clusters (Corander et al., 2004, 2008).

The individual plasmid alignment was generated by extracting the part of the combined plasmid/chromosome alignment that contained plasmid sequence only. This alignment was then analysed on its own. Following SNP calling, this produced a SNP alignment of 4784 bp that was used to generate an unrooted phylogeny and perform BAPS clustering (as above) within the plasmid population.

To examine the temporal and phylogeographic distribution of the samples we made use of BEAST, providing taxa subsets of the recombination-free alignment and providing geographic information and sample dates. The parameters were as follows: a Bayesian skyline model for population growth was used, with a log-normally distributed clock rate. For each PG BEAST was run across five chains of 100,000,000 generations each, sampled every 1000 generations. Convergence was determined by visual inspection of MCMC parameters across the chains. All parameter ESS values were ≥200. The parameter and tree estimates were combined using the LogCombiner and TreeAnnotator components of the BEAST package, with the first 10% of states in each chain discarded as burn-in, and then produced a Maximum Clade Credibility tree from the combined file, which was visualized with FigTree.

The presence of virulence and AMR determinants (Figure 2) was determined by BLAST against reference loci as described previously (Reuter et al., 2014). For the AMR genes (Figure 2) the presence of mutations in the DNA gyrase and topoisomerase IV protein sequences were assessed by inspection of de novo assembled sequences.

Acknowledgements

TRC, KSB, JP and NRT were all funded by the Wellcome Trust, grant number 098051. CRB was funded by a Wellcome Trust/NISCHR ISSF project at Cardiff University. The Bioinformatics analysis performed at Cardiff used resources funded by the MRC (Grant ref: MR/L015080/1) and Cardiff University (storage funded by the Cardiff University Research Infrastructure Fund). FXW and MG are funded by the Institut Pasteur, the Institut de Veille Sanitaire, and by the French Government ‘Investissement d'Avenir’ program (Integrative Biology of Emerging Infectious Diseases Laboratory of Excellence, grant no. ANR-10-LABX-62-IBEID). DWK was supported by the grant 2012R1A2A2A01009741 from National Research Foundation (NRF) of Korea. We thank David Harris and the sequencing teams at the Sanger Institute for sequencing the samples. We thank Dr Munirul Alam, icddr,b for the helpful discussions and we thank Isabelle Carle, Monique Lejay-Collin, Corinne Ruckly from the Institut Pasteur for their excellent technical assistance.

Funding Statement

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Funding Information

This paper was supported by the following grants:

  • Wellcome Trust 098051 to Thomas R Connor, Kate S Baker, Julian Parkhill, Nicholas R Thomson.

  • Medical Research Council (MRC) MR/L015080/1 to Thomas R Connor.

  • Cardiff University to Thomas R Connor, Clare R Barker.

  • Institut Pasteur to François-Xavier Weill, Malika Gouali.

  • Institut de veille sanitaire to François-Xavier Weill, Malika Gouali.

  • Government of the French Republic ANR-10-LABX-62-IBEID to François-Xavier Weill, Malika Gouali.

  • National Research Foundation of Korea 2012R1A2A2A01009741 to Dong Wook Kim.

  • Wellcome Trust/National Institute for Social Care and Health Research ISSF grant to Cardiff University to Clare R Barker.

Additional information

Competing interests

The authors declare that no competing interests exist.

Author contributions

TRC, Conception and design, Acquisition of data, Analysis and interpretation of data, Drafting or revising the article.

DWK, Conception and design, Acquisition of data, Analysis and interpretation of data, Drafting or revising the article.

CRB, Analysis and interpretation of data, Drafting or revising the article.

KSB, Analysis and interpretation of data, Drafting or revising the article.

F-XW, Conception and design, Acquisition of data, Drafting or revising the article, Contributed unpublished essential data or reagents.

KAT, Conception and design, Acquisition of data, Drafting or revising the article, Contributed unpublished essential data or reagents.

AMS, Acquisition of data, Drafting or revising the article, Contributed unpublished essential data or reagents.

SB, Acquisition of data, Drafting or revising the article, Contributed unpublished essential data or reagents.

SMF, Acquisition of data, Drafting or revising the article, Contributed unpublished essential data or reagents.

MG, Acquisition of data, Drafting or revising the article.

DPT, Acquisition of data, Drafting or revising the article.

IJA, Acquisition of data, Drafting or revising the article.

WDS, Drafting or revising the article, Contributed unpublished essential data or reagents.

TS, Analysis and interpretation of data, Drafting or revising the article, Contributed unpublished essential data or reagents.

LHW, Analysis and interpretation of data, Drafting or revising the article, Contributed unpublished essential data or reagents.

CJ, Conception and design, Drafting or revising the article.

AC, Conception and design, Acquisition of data, Drafting or revising the article.

JP, Conception and design, Drafting or revising the article, Contributed unpublished essential data or reagents.

KHK, Conception and design, Analysis and interpretation of data, Drafting or revising the article, Contributed unpublished essential data or reagents.

NRT, Conception and design, Analysis and interpretation of data, Drafting or revising the article, Contributed unpublished essential data or reagents.

Additional files

Supplementary file 1.

Table containing strain information, accession numbers for the strains used in this study along with the blast identities for the virulence and AMR genes displayed in Figure 2.

DOI: http://dx.doi.org/10.7554/eLife.07335.016

elife07335s001.xlsx (109.4KB, xlsx)
DOI: 10.7554/eLife.07335.016

Major datasets

The following datasets were generated:

The Shigella Genome Sequencing Consortium, 2015, Global Diversity of Shigella Species, http://www.ncbi.nlm.nih.gov/bioproject/?term=PRJEB2846, Publicly available at the NCBI BioProject (Accession no: PRJEB2846).

The Shigella Genome Sequencing Consortium, 2015, Shigella sonnei and flexneri from around the world, http://www.ncbi.nlm.nih.gov/bioproject/204320, Publicly available at the NCBI BioProject (Accession no: PRJEB2460).

The Shigella Genome Sequencing Consortium, 2015, Shigella flexneri from around the world, http://www.ncbi.nlm.nih.gov/bioproject/?term=PRJEB2542, Publicly available at the NCBI BioProject (Accession no: PRJEB2542).

References

  1. Al-Hasani K, Henderson IR, Sakellaris H, Rajakumar K, Grant T, Nataro JP, Robins-Browne R, Adler B. The sigA gene which is borne on the she pathogenicity island of Shigella flexneri 2a encodes an exported cytopathic protease involved in intestinal fluid accumulation. Infection and Immunity. 2000;68:2457–2463. doi: 10.1128/IAI.68.5.2457-2463.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Allison GE, Verma NK. Serotype-converting bacteriophages and O-antigen modification in Shigella flexneri. Trends in Microbiology. 2000;8:17–23. doi: 10.1016/S0966-842X(99)01646-7. [DOI] [PubMed] [Google Scholar]
  3. Ashton PM, Baker KS, Gentle A, Wooldridge DJ, Thomson NR, Dallman TJ, Jenkins C. Draft genome sequences of the type strains of Shigella flexneri held at Public Health England: comparison of classical phenotypic and novel molecular assays with whole genome sequence. Gut Pathogens. 2014;6:7. doi: 10.1186/1757-4749-6-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Baker KS, Dallman TJ, Ashton PM, Day M, Hughes G, Crook PD, Gilbart VL, Zittermann S, Allen VG, Howden BP, Tomita T, Valcanis M, Harris SR, Connor TR, Sintchenko V, Howard P, Brown JD, Petty NK, Gouali M, Thanh DP, Keddy KH, Smith AM, Talukder KA, Faruque SM, Parkhill J, Baker S, Weill FX, Jenkins C, Thomson NR. Intercontinental dissemination of azithromycin-resistant shigellosis through sexual transmission: a cross-sectional study. The Lancet. Infectious Diseases. 2015 doi: 10.1016/S1473-3099(15)00002-X. [DOI] [PubMed] [Google Scholar]
  5. Baker KS, Mather AE, McGregor H, Coupland P, Langridge GC, Day M, Deheer-Graham A, Parkhill J, Russell JE, Thomson NR. The extant World War 1 dysentery bacillus NCTC1: a genomic analysis. Lancet. 2014;384:1691–1697. doi: 10.1016/S0140-6736(14)61789-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cheng L, Connor TR, Aanensen DM, Spratt BG, Corander J. Bayesian semi-supervised classification of bacterial samples using MLST databases. BMC Bioinformatics. 2011;12:302. doi: 10.1186/1471-2105-12-302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cheng L, Connor TR, Siren J, Aanensen DM, Corander J. Hierarchical and spatially explicit clustering of DNA sequences with BAPS software. Molecular Biology and Evolution. 2013;30:1224–1228. doi: 10.1093/molbev/mst028. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Choi SY, Jeon YS, Lee JH, Choi B, Moon SH, von Seidlein L, Clemens JD, Dougan G, Wain J, Yu J, Lee JC, Seol SY, Lee BK, Song JH, Song M, Czerkinsky C, Chun J, Kim DW. Multilocus sequence typing analysis of Shigella flexneri isolates collected in Asian countries. Journal of Medical Microbiology. 2007;56:1460–1466. doi: 10.1099/jmm.0.47322-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Corander J, Marttinen P, Siren J, Tang J. Enhanced Bayesian modelling in BAPS software for learning genetic structures of populations. BMC Bioinformatics. 2008;9:539. doi: 10.1186/1471-2105-9-539. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Corander J, Waldmann P, Marttinen P, Sillanpaa MJ. BAPS 2: enhanced possibilities for the analysis of genetic population structure. Bioinformatics. 2004;20:2363–2369. doi: 10.1093/bioinformatics/bth250. [DOI] [PubMed] [Google Scholar]
  11. Croucher NJ, Page AJ, Connor TR, Delaney AJ, Keane JA, Bentley SD, Parkhill J, Harris SR. Rapid phylogenetic analysis of large samples of recombinant bacterial whole genome sequences using Gubbins. Nucleic Acids Research. 2014;43:e15. doi: 10.1093/nar/gku1196. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Drummond AJ, Rambaut A. BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evolutionary Biology. 2007;7:214. doi: 10.1186/1471-2148-7-214. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Edwards PR, Ewing WH. Edwards and Ewing's identification of enterobacteriaceae. New York: Elsevier; 1986. p. 536. [Google Scholar]
  14. Emch M, Ali M, Yunus M. Risk areas and neighborhood-level risk factors for Shigella dysenteriae 1 and Shigella flexneri. Health & Place. 2008;14:96–105. doi: 10.1016/j.healthplace.2007.05.004. [DOI] [PubMed] [Google Scholar]
  15. Esrey SA, Feachem RG, Hughes JM. Interventions for the control of diarrheal diseases among young-children - Improving water-supplies and excreta disposal facilities. Bulletin of the World Health Organization. 1985;63:757–772. [PMC free article] [PubMed] [Google Scholar]
  16. Faruque SM, Khan R, Kamruzzaman M, Yamasaki S, Ahmad QS, Azim T, Nair GB, Takeda Y, Sack DA. Isolation of Shigella dysenteriae type 1 and S. flexneri strains from surface waters in Bangladesh: comparative molecular analysis of environmental Shigella isolates versus clinical strains. Applied and Environmental Microbiology. 2002;68:3908–3913. doi: 10.1128/AEM.68.8.3908-3913.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Fasano A, Noriega FR, Liao FM, Wang W, Levine MM. Effect of Shigella enterotoxin 1 (ShET1) on rabbit intestine in vitro and in vivo. Gut. 1997;40:505–511. doi: 10.1136/gut.40.4.505. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Gray MD, Lampel KA, Strockbine NA, Fernandez RE, Melton-Celsa AR, Maurelli AT. Clinical isolates of shiga toxin 1a-producing Shigella flexneri with an epidemiological link to recent travel to Hispaniola. Emerging Infectious Diseases. 2014;20:1669–1677. doi: 10.3201/eid2010.140292. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. He F, Han K, Liu L, Sun W, Zhang L, Zhu B, Ma H. Shigellosis outbreak associated with contaminated well water in a rural elementary school: Sichuan Province, China, June 7–16, 2009. PLOS ONE. 2012;7:e47239. doi: 10.1371/journal.pone.0047239. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. He M, Miyajima F, Roberts P, Ellison L, Pickard DJ, Martin MJ, Connor TR, Harris SR, Fairley D, Bamford KB, D'Arc S, Brazier J, Brown D, Coia JE, Douce G, Gerding D, Kim HJ, Koh TH, Kato H, Senoh M, Louie T, Michell S, Butt E, Peacock SJ, Brown NM, Riley T, Songer G, Wilcox M, Pirmohamed M, Kuijper E, Hawkey P, Wren BW, Dougan G, Parkhill J, Lawley TD. Emergence and global spread of epidemic healthcare-associated Clostridium difficile. Nature Genetics. 2013;45:109–113. doi: 10.1038/ng.2478. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Henderson IR, Czeczulin J, Eslava C, Noriega F, Nataro JP. Characterization of pic, a secreted protease of Shigella flexneri and enteroaggregative Escherichia coli. Infection and Immunity. 1999;67:5587–5596. doi: 10.1128/iai.67.11.5587-5596.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Hendricks CW, Morrison SM. Multiplication and growth of selected enteric bacteria in clear mountain stream water. Water Research. 1967;1:567–576. doi: 10.1016/0043-1354(67)90039-5. [DOI] [Google Scholar]
  23. Holt KE, Baker S, Weill FX, Holmes EC, Kitchen A, Yu J, Sangal V, Brown DJ, Coia JE, Kim DW, Choi SY, Kim SH, da Silveira WD, Pickard DJ, Farrar JJ, Parkhill J, Dougan G, Thomson NR. Shigella sonnei genome sequencing and phylogenetic analysis indicate recent global dissemination from Europe. Nature Genetics. 2012;44:1056–1059. doi: 10.1038/ng.2369. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Holt KE, Thieu Nga TV, Thanh DP, Vinh H, Kim DW, Vu Tra MP, Campbell JI, Hoang NV, Vinh NT, Minh PV, Thuy CT, Nga TT, Thompson C, Dung TT, Nhu NT, Vinh PV, Tuyet PT, Phuc HL, Lien NT, Phu BD, Ai NT, Tien NM, Dong N, Parry CM, Hien TT, Farrar JJ, Parkhill J, Dougan G, Thomson NR, Baker S. Tracking the establishment of local endemic populations of an emergent enteric pathogen. Proceedings of the National Academy of Sciences of USA. 2013;110:17522–17527. doi: 10.1073/pnas.1308632110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Islam MS, Hasan MK, Khan SI. Growth and survival of Shigella flexneri in common Bangladeshi foods under various conditions of time and temperature. Applied and Environmental Microbiology. 1993;59:652–654. doi: 10.1128/aem.59.2.652-654.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Islam MS, Rezwan FB, Khan SI. Survival of Shigella flexneri in artificial aquatic environment: effects of different physicochemical stress factors. Journal of Diarrhoeal Diseases Research. 1996;14:37–40. [PubMed] [Google Scholar]
  27. Karaolis DK, Lan R, Reeves PR. Sequence variation in Shigella sonnei (Sonnei), a pathogenic clone of Escherichia coli, over four continents and 41 years. Journal of Clinical Microbiology. 1994;32:796–802. doi: 10.1128/jcm.32.3.796-802.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Kotloff KL, Nataro JP, Blackwelder WC, Nasrin D, Farag TH, Panchalingam S, Wu Y, Sow SO, Sur D, Breiman RF, Faruque AS, Zaidi AK, Saha D, Alonso PL, Tamboura B, Sanogo D, Onwuchekwa U, Manna B, Ramamurthy T, Kanungo S, Ochieng JB, Omore R, Oundo JO, Hossain A, Das SK, Ahmed S, Qureshi S, Quadri F, Adegbola RA, Antonio M, Hossain MJ, Akinsola A, Mandomando I, Nhampossa T, Acácio S, Biswas K, O'Reilly CE, Mintz ED, Berkeley LY, Muhsen K, Sommerfelt H, Robins-Browne RM, Levine MM. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet. 2013;382:209–222. doi: 10.1016/S0140-6736(13)60844-2. [DOI] [PubMed] [Google Scholar]
  29. Kotloff KL, Winickoff JP, Ivanoff B, Clemens JD, Swerdlow DL, Sansonetti PJ, Adak GK, Levine MM. Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. Bulletin of the World Health Organization. 1999;77:651–666. [PMC free article] [PubMed] [Google Scholar]
  30. Lawlor KM, Daskaleros PA, Robinson RE, Payne SM. Virulence of iron transport mutants of Shigella flexneri and utilization of host iron compounds. Infection and Immunity. 1987;55:594–599. doi: 10.1128/iai.55.3.594-599.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Livio S, Strockbine NA, Panchalingam S, Tennant SM, Barry EM, Marohn ME, Antonio M, Hossain A, Mandomando I, Ochieng JB, Oundo JO, Qureshi S, Ramamurthy T, Tamboura B, Adegbola RA, Hossain MJ, Saha D, Sen S, Faruque AS, Alonso PL, Breiman RF, Zaidi AK, Sur D, Sow SO, Berkeley LY, O'Reilly CE, Mintz ED, Biswas K, Cohen D, Farag TH, Nasrin D, Wu Y, Blackwelder WC, Kotloff KL, Nataro JP, Levine MM. Shigella isolates from the global enteric multicenter study inform vaccine development. Clinical Infectious Diseases. 2014;59:933–941. doi: 10.1093/cid/ciu468. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Luck SN, Turner SA, Rajakumar K, Sakellaris H, Adler B. Ferric dicitrate transport system (Fec) of Shigella flexneri 2a YSH6000 is encoded on a novel pathogenicity island carrying multiple antibiotic resistance genes. Infection and Immunity. 2001;69:6012–6021. doi: 10.1128/IAI.69.10.6012-6021.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Mather AE, Reid SW, Maskell DJ, Parkhill J, Fookes MC, Harris SR, Brown DJ, Coia JE, Mulvey MR, Gilmour MW, Petrovska L, de Pinna E, Kuroda M, Akiba M, Izumiya H, Connor TR, Suchard MA, Lemey P, Mellor DJ, Haydon DT, Thomson NR. Distinguishable epidemics of multidrug-resistant Salmonella typhimurium DT104 in different hosts. Science. 2013;341:1514–1517. doi: 10.1126/science.1240578. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. McNally A, Cheng L, Harris SR, Corander J. The evolutionary path to extraintestinal pathogenic, drug-resistant Escherichia coli is marked by drastic reduction in detectable recombination within the core genome. Genome Biology and Evolution. 2013;5:699–710. doi: 10.1093/gbe/evt038. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Mutreja A, Kim DW, Thomson NR, Connor TR, Lee JH, Kariuki S, Croucher NJ, Choi SY, Harris SR, Lebens M, Niyogi SK, Kim EJ, Ramamurthy T, Chun J, Wood JL, Clemens JD, Czerkinsky C, Nair GB, Holmgren J, Parkhill J, Dougan G. Evidence for several waves of global transmission in the seventh cholera pandemic. Nature. 2011;477:462–465. doi: 10.1038/nature10392. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Noriega FR, Liao FM, Formal SB, Fasano A, Levine MM. Prevalence of Shigella enterotoxin 1 among Shigella clinical isolates of diverse serotypes. The Journal of Infectious Diseases. 1995;172:1408–1410. doi: 10.1093/infdis/172.5.1408. [DOI] [PubMed] [Google Scholar]
  37. O'Brien IG, Gibson F. The structure of enterochelin and related 2,3-dihydroxy-N-benzoylserine conjugates from Escherichia coli. Biochimica et Biophysica Acta. 1970;215:393–402. doi: 10.1016/0304-4165(70)90038-3. [DOI] [PubMed] [Google Scholar]
  38. Okoro CK, Kingsley RA, Connor TR, Harris SR, Parry CM, Al-Mashhadani MN, Kariuki S, Msefula CL, Gordon MA, de Pinna E, Wain J, Heyderman RS, Obaro S, Alonso PL, Mandomando I, MacLennan CA, Tapia MD, Levine MM, Tennant SM, Parkhill J, Dougan G. Intracontinental spread of human invasive Salmonella typhimurium pathovariants in sub-Saharan Africa. Nature Genetics. 2012;44:1215–1221. doi: 10.1038/ng.2423. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Otto TD, Sanders M, Berriman M, Newbold C. Iterative Correction of Reference Nucleotides (iCORN) using second generation sequencing technology. Bioinformatics. 2010;26:1704–1707. doi: 10.1093/bioinformatics/btq269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Pupo GM, Lan R, Reeves PR. Multiple independent origins of Shigella clones of Escherichia coli and convergent evolution of many of their characteristics. Proceedings of the National Academy of Sciences of the USA. 2000;97:10567–10572. doi: 10.1073/pnas.180094797. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Ram PK, Crump JA, Gupta SK, Miller MA, Mintz ED. Part II. Analysis of data gaps pertaining to Shigella infections in low and medium human development index countries, 1984-2005. Epidemiology and Infection. 2008;136:577–603. doi: 10.1017/S0950268807009351. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Reuter S, Connor TR, Barquist L, Walker D, Feltwell T, Harris SR, Fookes M, Hall ME, Petty NK, Fuchs TM, Corander J, Dufour M, Ringwood T, Savin C, Bouchier C, Martin L, Miettinen M, Shubin M, Riehm JM, Laukkanen-Ninios R, Sihvonen LM, Siitonen A, Skurnik M, Falcão JP, Fukushima H, Scholz HC, Prentice MB, Wren BW, Parkhill J, Carniel E, Achtman M, McNally A, Thomson NR. Parallel independent evolution of pathogenicity within the genus Yersinia. Proceedings of the National Academy of Sciences of the USA. 2014;111:6768–6773. doi: 10.1073/pnas.1317161111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Rohmer L, Jacobs MA, Brittnacher MJ, Fong C, Hayden HS, Hocquet D, Weiss EJ, Radey M, Germani Y, Talukder KA, Hager AJ, Kemner JM, Sims-Day EH, Matamouros S, Hager KR, Miller SI. Genomic analysis of the emergence of 20th century epidemic dysentery. BMC Genomics. 2014;15:355. doi: 10.1186/1471-2164-15-355. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Runyen-Janecky LJ, Reeves SA, Gonzales EG, Payne SM. Contribution of the Shigella flexneri Sit, Iuc, and Feo iron acquisition systems to iron acquisition in vitro and in cultured cells. Infection and Immunity. 2003;71:1919–1928. doi: 10.1128/IAI.71.4.1919-1928.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Sack DA, Hoque S, Etheridge M, Huq A. Is protection against shigellosis induced by natural infection with Plesiomonas shigelloides? Lancet. 1994;343:1413–1415. doi: 10.1016/S0140-6736(94)92531-3. [DOI] [PubMed] [Google Scholar]
  46. Saha T, Murhekar M, Hutin YJ, Ramamurthy T. An urban, water-borne outbreak of diarrhoea and shigellosis in a district town in eastern India. The National Medical Journal of India. 2009;22:237–239. [PubMed] [Google Scholar]
  47. Sahl JW, Morris CR, Emberger J, Fraser CM, Ochieng JB, Juma J, Fields B, Breiman RF, Gilmour M, Nataro JP, Rasko DA. Defining the phylogenomics of Shigella species: a pathway to diagnostics. Journal of Clinical Microbiology. 2015;53:951–960. doi: 10.1128/JCM.03527-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Sansonetti PJ, Kopecko DJ, Formal SB. Involvement of a plasmid in the invasive ability of Shigella flexneri. Infection and Immunity. 1982;35:852–860. doi: 10.1128/iai.35.3.852-860.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Schmitt MP, Payne SM. Genetics and regulation of enterobactin genes in Shigella flexneri. Journal of Bacteriology. 1988;170:5579–5587. doi: 10.1128/jb.170.12.5579-5587.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Stamatakis A. RAxML-VI-HPC: maximum likelihood-based phylogenetic analyses with thousands of taxa and mixed models. Bioinformatics. 2006;22:2688–2690. doi: 10.1093/bioinformatics/btl446. [DOI] [PubMed] [Google Scholar]
  51. Sun Q, Lan R, Wang Y, Zhao A, Zhang S, Wang J, Wang Y, Xia S, Jin D, Cui Z, Zhao H, Li Z, Ye C, Zhang S, Jing H, Xu J. Development of a multiplex PCR assay targeting O-antigen modification genes for molecular serotyping of Shigella flexneri. Journal of Clinical Microbiology. 2011;49:3766–3770. doi: 10.1128/JCM.01259-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Swaddiwudhipong W, Karintraratana S, Kavinum S. A common-source outbreak of shigellosis involving a piped public water supply in northern Thai communities. The Journal of Tropical Medicine and Hygiene. 1995;98:145–150. [PubMed] [Google Scholar]
  53. The Shigella Genome Sequencing Consortium 2015a. Global Diversity of Shigella Species. NCBI BioProject PRJEB2846. http://www.ncbi.nlm.nih.gov/bioproject/?term=PRJEB2846.
  54. The Shigella Genome Sequencing Consortium 2015b. Shigella sonnei and flexneri from around the world. NCBI BioProject PRJEB2460. http://www.ncbi.nlm.nih.gov/bioproject/204320.
  55. The Shigella Genome Sequencing Consortium 2015c. Shigella flexneri from around the world. NCBI BioProject PRJEB2542. http://www.ncbi.nlm.nih.gov/bioproject/?term=PRJEB2542.
  56. Ud-Din AI, Wahid SU, Latif HA, Shahnaij M, Akter M, Azmi IJ, Hasan TN, Ahmed D, Hossain MA, Faruque AS, Faruque SM, Talukder KA. Changing trends in the prevalence of Shigella species: emergence of multi-drug resistant Shigella sonnei biotype g in Bangladesh. PLOS ONE. 2013;8:e82601. doi: 10.1371/journal.pone.0082601. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Uyanik MH, Yazgi H, Ayyildiz A. Survival of Salmonella typhi and Shigella flexneri in different water samples and at different temperatures. Turkish Journal of Medical Sciences. 2008;38:307–310. [Google Scholar]
  58. Vinh H, Nhu NT, Nga TV, Duy PT, Campbell JI, Hoang NV, Boni MF, My PV, Parry C, Nga TT, Van Minh P, Thuy CT, Diep TS, Phuong le T, Chinh MT, Loan HT, Tham NT, Lanh MN, Mong BL, Anh VT, Bay PV, Chau NV, Farrar J, Baker S. A changing picture of shigellosis in southern Vietnam: shifting species dominance, antimicrobial susceptibility and clinical presentation. BMC Infectious Diseases. 2009;9:204. doi: 10.1186/1471-2334-9-204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. von Mentzer A, Connor TR, Wieler LH, Semmler T, Iguchi A, Iguchi A, Thomson NR, Rasko DA, Joffre E, Corander J, Pickard D, Wiklund G, Svennerholm AM, Sjöling Å, Dougan G. Identification of enterotoxigenic Escherichia coli (ETEC) clades with long-term global distribution. Nature Genetics. 2014;46:1321–1326. doi: 10.1038/ng.3145. [DOI] [PubMed] [Google Scholar]
  60. von Seidlein L, Kim DR, Ali M, Lee H, Wang X, Thiem VD, Canh do G, Chaicumpa W, Agtini MD, Hossain A, Bhutta ZA, Mason C, Sethabutr O, Talukder K, Nair GB, Deen JL, Kotloff K, Clemens J. A multicentre study of Shigella diarrhoea in six Asian countries: disease burden, clinical manifestations, and microbiology. PLOS Medicine. 2006;3:e353. doi: 10.1371/journal.pmed.0030353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Wyckoff EE, Boulette ML, Payne SM. Genetics and environmental regulation of Shigella iron transport systems. Biometals. 2009;22:43–51. doi: 10.1007/s10534-008-9188-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Yang F, Yang J, Zhang X, Chen L, Jiang Y, Yan Y, Tang X, Wang J, Xiong Z, Dong J, Xue Y, Zhu Y, Xu X, Sun L, Chen S, Nie H, Peng J, Xu J, Wang Y, Yuan Z, Wen Y, Yao Z, Shen Y, Qiang B, Hou Y, Yu J, Jin Q. Genome dynamics and diversity of Shigella species, the etiologic agents of bacillary dysentery. Nucleic Acids Research. 2005;33:6445–6458. doi: 10.1093/nar/gki954. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Yang YG, Song MK, Park SJ, Kim SW. Direct detection of Shigella flexneri and Salmonella typhimurium in human feces by real-time PCR. Journal of Microbiology and Biotechnology. 2007;17:1616–1621. [PubMed] [Google Scholar]
  64. Zerbino DR, Birney E. Velvet: algorithms for de novo short read assembly using de Bruijn graphs. Genome Research. 2008;18:821–829. doi: 10.1101/gr.074492.107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Zhang N, Lan R, Sun Q, Wang J, Wang Y, Zhang J, Yu D, Hu W, Hu S, Dai H, Du P, Wang H, Xu J. Genomic portrait of the evolution and epidemic spread of a recently emerged multidrug-resistant Shigella flexneri clone in China. Journal of Clinical Microbiology. 2014;52:1119–1126. doi: 10.1128/JCM.02669-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
eLife. 2015 Aug 4;4:e07335. doi: 10.7554/eLife.07335.017

Decision letter

Editor: Diethard Tautz1

eLife posts the editorial decision letter and author response on a selection of the published articles (subject to the approval of the authors). An edited version of the letter sent to the authors after peer review is shown, indicating the substantive concerns or comments; minor concerns are not usually shown. Reviewers have the opportunity to discuss the decision before the letter is sent (see review process). Similarly, the author response typically shows only responses to the major concerns raised by the reviewers.

Thank you for submitting your work entitled “Species-wide whole genome sequencing reveals historical global spread and recent local persistence in Shigella flexneri” for peer review at eLife. Your submission has been favorably evaluated by Diethard Tautz (Senior editor) and two reviewers, one of whom, Allan McNally, has agreed to share his identity.

The reviewers have discussed the reviews with one another, and the editor has drafted this decision to help you prepare a revised submission.

Summary:

The authors present a comprehensive analysis of the evolution of Shigella flexneri. The work is excellently conducted and the conclusions drawn in the manuscript are sound and solidly supported by the data. The contrast presented in the manuscript between S. flexneri and S. sonnei make this more than just another species phylogeny paper, showing very interesting insights into the effect of socio-demographic influences on how pathogenic lineages of bacteria evolve.

Essential revisions:

1) Looking at the section on AMR and the phylogeny it seems that PG3, which contains the serotype 2a clinically dominant strains, is the most recently emerged of the phylogroups. When one looks at the mapping of the AMR genes the low-diversity bottom half of PG3 appears to have a near identical AMR pattern. So whilst you state there is no effect of AMR on the evolution of S. flexneri lineages and dissemination, one could argue that PG3 shows signs of clonal expansion of an AMR lineage? Please clarify.

Further to this point on the discussion that AMR is not an absolute requirement for modern S. flexneri. Is it not plausible that the patchwork appearance of AMR seen in the majority of the PGS may be due to transient carriage of AMR genes? Such that they are only maintained for short periods of time when selection for them is great, but then they are rapidly lost during the hypothesised environmental phase of their life cycle?

2) We consider the suggestion of a different life style or a different life-cycle between S. flexneri and other Shigella species as a very interesting hypothesis and very important to the field, if true. However, such an interpretation of the genomics data ideally requires further experimental support. As far as we know, Shigella has no environmental reservoir and human is its only host. You cite a paper reporting the isolation of S. flexneri from the environment (Faruque et al., 2002); however, similar numbers of S. dysenteriae were also isolated from these environmental samples and therefore, do not support a different life style of S. flexneri than other Shigella species. Furthermore, different virulence genes (ipaBCD) from the virulence plasmid were missing in these so-called environmental isolates, but were present in clinical isolates, suggesting avirulent phenotype of these isolates.

It would therefore be prudent to provide more evidence for an environmental persistence of S. flexneri, for example from genome sequences of food or environmental isolates. Are these available in your collection? Further, it might be useful to check for clues in the genome why S. flexneri might be more persistent in the environment. Are there any differences in carbon or nitrogen utilization pathways (different number of pseudogenes) in relation to S. Sonnei?

Alternatively, we suggest a test in the lab. A controlled comparison of the survival of Shigella species in water can provide strong experimental support for such an assumption and possibly explain the different epidemiology of S. flexneri vs. S. Sonnei.

In case that neither the bioinformatic analysis provide additional clues nor the experimental approach is feasible, we would ask you to clearly explain the caveats associated with your assumption of different life styles.

3) A slight weakness is that recent S. flexneri isolates from European origin are underrepresented in the collection. It appears that the most recent European strain (E2610/72) was from 1972. As global tourism from endemic countries to Europe increased greatly in the last 40 years or so, facilitating a possible intercontinental transmission might be overlooked if recent isolates are not included. For example of a recent outbreak in Europe, please see: M L Borg Ongoing outbreak of Shigella flexneri serotype 3a in men who have sex with men in England and Wales, data from 2009-2011. Eurosurveillance, Volume 17, 2012. Accordingly, we should like to ask you to assess the possibility to add more recent isolates from Europe in your study.

eLife. 2015 Aug 4;4:e07335. doi: 10.7554/eLife.07335.018

Author response

1) Looking at the section on AMR and the phylogeny it seems that PG3, which contains the serotype 2a clinically dominant strains, is the most recently emerged of the phylogroups. When one looks at the mapping of the AMR genes the low-diversity bottom half of PG3 appears to have a near identical AMR pattern. So whilst you state there is no effect of AMR on the evolution of S. flexneri lineages and dissemination, one could argue that PG3 shows signs of clonal expansion of an AMR lineage? Please clarify.

We agree that this needs clarifying, and would say that we did not intend to suggest that there is ‘no effect’ as an absolute, rather within our dataset we do not believe there is strong historical evidence for the effect of AMR on the species as a whole. In the specific case highlighted the SNP distance between most isolates in PG3 is >100 SNPs. This is not consistent with a very recent clonal expansion but as you point out it does not exclude the possibility of this happening. Furthermore we do know of one unique case where – in the MSM population, as indicated below – an S. flexneri clone has spread by clonal expansion related to AMR. To address this point we have modified a section of our AMR results section to read:

“While published evidence does exist of one major, on-going, clonal outbreak of S. flexneri in high income countries that has been shown to be the result of a combination of specific epidemiological, antimicrobial resistance and behavioral factors within the MSM community [Baker et al., 2015], examining our dataset focused around historical isolates and those with an origin in low-income countries, we observe limited historical evidence of global expansion as a result of antimicrobial resistance. In contrast we observe the widespread acquisition of AMR determinants independently across the tree.”

Further to this point on the discussion that AMR is not an absolute requirement for modern S. flexneri. Is it not plausible that the patchwork appearance of AMR seen in the majority of the PGS may be due to transient carriage of AMR genes? Such that they are only maintained for short periods of time when selection for them is great, but then they are rapidly lost during the hypothesised environmental phase of their life cycle?

It is certainly possible. Our intention in stating that AMR is not an absolute requirement was a general commentary on the fact that over the whole population the pattern of AMR gain and loss was markedly different from other pathogenic Shigella species, such as S. sonnei, where strain/lineage replacement appears to now be driven by the acquisition of AMR. This pattern is clearly not present within S. flexneri .

The reviewer points to a possible mechanism that would drive this observation. Although this is complicated by the fact that a subset of the AMR genes are carried by the (chromosomal) SRL-PAI which is more stable, we agree, that one explanation, especially for possible plasmid encoded functions, may very well be transient carriage. To address this point we have added this line to the Discussion:

“It may be that the transient nature of AMR gene carriage is the result of rapid gain and loss during periods of differential selection, consistent with S. flexneri persisting in the environment where it is conceivable that selection by could be AMR less significant.”

2) We consider the suggestion of a different life style or a different life-cycle between S. flexneri and other Shigella species as a very interesting hypothesis and very important to the field, if true. However, such an interpretation of the genomics data ideally requires further experimental support. As far as we know, Shigella has no environmental reservoir and human is its only host. You cite a paper reporting the isolation of S. flexneri from the environment (Faruque et al., 2002); however, similar numbers of S. dysenteriae were also isolated from these environmental samples and therefore, do not support a different life style of S. flexneri than other Shigella species. Furthermore, different virulence genes (ipaBCD) from the virulence plasmid were missing in these so-called environmental isolates, but were present in clinical isolates, suggesting avirulent phenotype of these isolates.

It would therefore be prudent to provide more evidence for an environmental persistence of S. flexneri, for example from genome sequences of food or environmental isolates. Are these available in your collection?

Our intention with the inclusion of Baker et al., 2002 was to point towards the fact that S. flexneri could be isolated from water unlinked to any outbreak. We realize that we should have made this clearer and have updated the text to reflect our intention when citing that reference. We also realise that we should have been clearer about previous evidence for the isolation of S. flexneri strains that are linked to outbreaks from water sources – there are a number of publications that have linked cases/outbreaks of S. flexneri disease to water sources, and we have updated the text to reflect this. These include cases in China (He et al., 2012), India (Saha et al., 2009) and Thailand (Swaddiwudhipong et al., 1995). In all of these other cases, not only was S. flexneri isolated from the environment and cause of local disease; in these studies it was also the only Shigella species isolated from the water sources examined. Additionally, we have also referenced a further study conducted in Bangladesh (Emch et al., 2008) which demonstrated that a) S. flexneri risk areas are consistent based on geography (suggesting that the primary risk factors for S. flexneri disease in their study area are environmental, compared to S. dysenteriae where the risk factors were temporal and not linked to geographic location) and b) that there was a correlation between S. flexneri risk and the type of area that an individual lived in, which was directly related to likely exposure to water (flood controlled/not flood controlled).

With regard to our samples over 85% were isolated from human clinical cases for this study, while the remaining strains (which are all historical) are likely to be of clinical origin, although the metadata for these strains is often confusing and poorly recorded. Environmental isolates are not routinely collected especially in endemic regions and none were collected by our partner institutes over the time period covered by this study and in fact it is surprisingly hard to isolate many bacterial agents of diarrheal disease directly from the environment except in close proximity to latrines or where people practice open defecation. This is however very much in our future plans for prospective collection of true environmental isolates. However, collectively we believe that our data and previous published work provides a large body of data to support to the idea that a) S. flexneri can be isolated from the environment and b) that S. flexneri from an environmental source can be linked to clinical disease. To address these points we have added the references detailed above, with some additional text to our Discussion:

“It has previously been shown that S. flexneri strains can be recovered […] and has been doing so over the long term, in countries around the world.”

Further, it might be useful to check for clues in the genome why S. flexneri might be more persistent in the environment. Are there any differences in carbon or nitrogen utilization pathways (different number of pseudogenes) in relation to S. Sonnei?

Alternatively, we suggest a test in the lab. A controlled comparison of the survival of Shigella species in water can provide strong experimental support for such an assumption and possibly explain the different epidemiology of S. flexneri vs. S. Sonnei.

In case that neither the bioinformatic analysis provide additional clues nor the experimental approach is feasible, we would ask you to clearly explain the caveats associated with your assumption of different life styles.

We agree and one of the reasons serotyping is so useful/widely used for distinguishing Shigella and E. coli is because of the considerable metabolic overlap between members of the E. coli species complex. As mentioned by you (Reviewer 1), Shigella are essentially specialized subtypes of E. coli, and as such there are a very limited number of reactions that separate different Shigella species and Shigella from E. coli. A more detailed genomic analysis (such as a pseudogene identification/comparison across the Shigella species, metabolic reconstruction) is warranted but would need to be performed in the context of all species and across E. coli too. This is a huge data set and considerable amount of work to do in a meaningful way.

In relation to the survival of Shigella in water we did not intend to suggest that the reason for the difference in prevalence was due to an inability of S. sonnei to survive at all in the environment. We have updated the text to make this distinction clearer. We agree that survival experiments would be fascinating but believe that in order to answer the question being posed would go considerably beyond the scope of this paper and would represent a significant amount of extra work to ensure that the experimental design for them was appropriate, and to provide results that are any more meaningful than data that already exists within the published literature. We had already cited work (Uyakik, Yazgi and Ayyildiz, 2008) that has examined the question of long term survival of S. flexneri in water, and found that in slightly saline water, S. flexneri could survive for >40 days in laboratory conditions. In our response to point 2 above we have added additional references around the established ability S. flexneri could survive and grow on various foodstuffs (Islam et al., 1993) along with further work (Islam et al., 1996, Hendricks and Morrison, 1967) that has similarly demonstrated that S. flexneri can survive in aqueous environments outside the host. Collectively, therefore, we believe that additional references and caveats will better enable the readership to assess the likely veracity of our hypothesis and to facilitate other groups who may wish to investigate the possibility of our idea for themselves.

3) A slight weakness is that recent S. flexneri isolates from European origin are underrepresented in the collection. It appears that the most recent European strain (E2610/72) was from 1972. As global tourism from endemic countries to Europe increased greatly in the last 40 years or so, facilitating a possible intercontinental transmission might be overlooked if recent isolates are not included. For example of a recent outbreak in Europe, please see: M L Borg Ongoing outbreak of Shigella flexneri serotype 3a in men who have sex with men in England and Wales, data from 2009-2011. Eurosurveillance, Volume 17, 2012. Accordingly, we should like to ask you to assess the possibility to add more recent isolates from Europe in your study.

We agree with the importance of thinking about recent European isolates, and in that respect we point towards our recent article focusing exclusively on the genomic epidemiology of the Shigella flexnei 3a outbreak mentioned by the reviewer (Baker et al., 2015), and referenced within our paper as part of our response to revision 1. The MSM paper details the clonal expansion of specific Shigella flexneri 3a clones linked to specific epidemiological, antimicrobial resistance and behavioral factors in MSM where Shigella is behaving non-traditionally as a sexually transmitted infection.

The current article is looking at a very different population, and in so doing provides much needed context for this type of study. However, while we agree with the importance of European isolates we also believe that it should be understood that the focus of the work presented here is not the spread of disease within the MSM community, but rather detailing the patterns of transmission within endemic/low income regions (where the vast majority of the global disease burden of this pathogen continues to be found). On this basis we believe that the addition of strains from Europe – which would almost entirely be associated either with travel or the MSM community – would not add anything to the paper, and, in fact, would replicate work that has already been done elsewhere.

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Data Citations

    1. The Shigella Genome Sequencing Consortium 2015a. Global Diversity of Shigella Species. NCBI BioProject PRJEB2846. http://www.ncbi.nlm.nih.gov/bioproject/?term=PRJEB2846.
    2. The Shigella Genome Sequencing Consortium 2015b. Shigella sonnei and flexneri from around the world. NCBI BioProject PRJEB2460. http://www.ncbi.nlm.nih.gov/bioproject/204320.
    3. The Shigella Genome Sequencing Consortium 2015c. Shigella flexneri from around the world. NCBI BioProject PRJEB2542. http://www.ncbi.nlm.nih.gov/bioproject/?term=PRJEB2542.

    Supplementary Materials

    Supplementary file 1.

    Table containing strain information, accession numbers for the strains used in this study along with the blast identities for the virulence and AMR genes displayed in Figure 2.

    DOI: http://dx.doi.org/10.7554/eLife.07335.016

    elife07335s001.xlsx (109.4KB, xlsx)
    DOI: 10.7554/eLife.07335.016

    Articles from eLife are provided here courtesy of eLife Sciences Publications, Ltd

    RESOURCES